Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to compare the antidepressant efficacy and safety of two
doses of desvenlafaxine succinate sustained release (10 and 50 mg/day) in adults with Major
Depressive Disorder. The study will also assess changes in sexual function and general and
functional quality of life outcomes.